Seven cases of pancreatic serous cystadenoma were examined immunohisto
chemically and molecular biologically. Six were benign tumors and one
was clinically malignant. Immunohistochemical studies were performed w
ith the avidin-biotin peroxidase complex technique on paraffin embedde
d tumor tissue and were stained with antibody to carcinoembryonic anti
gen (CEA), CA19-9, and p53 protein. Two-stage polymerase chain reactio
n-restriction fragment length polymorphism analysis was used to detect
K-ras oncogene mutation at codon 12. No tumor cells were stained with
anti-CEA and anti-p53 protein, but two cases were stained focally wit
h anti-CA19-9. One case was benign and one was clinically malignant. I
n the anti-CA19-9 staining, tumor cells of the benign case were positi
ve only on the apical membrane and supranuclear cytoplasm of the cells
, whereas those of the clinically malignant case were positive over th
e entire surface and cytoplasm of the cells. All seven cases were with
out K-ras gene mutation. So the features of serous cystadenoma of the
pancreas suggest a tumor genesis different from that of ductal adenoca
rcinoma. They also suggest a relationship between immunohistochemical
localizations of CA19-9 in the tumor cells and the biological behavior
of the tumor itself.